Related Experiment Video
Updated: Mar 3, 2026

10:12
Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization
Published on: May 15, 2018
9.5K
High-Throughput Processing to Preserve Viable Cells: A Precision Medicine Initiative Cohort Program Workshop
Rebekah S Rasooly1, Daniel R Gossett1, Marianne K Henderson2
11 Division of Kidney, Urologic, and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, Maryland.
Biopreservation and Biobanking
|April 26, 2017
Summary
The All of Us Research Program is exploring the preservation of viable mononuclear blood cells. This aims to enable future single-cell analysis, advancing precision medicine and biomarker discovery.
Area of Science:
- Biorepository Science
- Precision Medicine
- Cellular Biology
Background:
- Traditional biobanks preserve various biological samples like serum, plasma, and tissues.
- Emerging single-cell analysis technologies drive interest in preserving viable blood cells.
- The All of Us Research Program aims to collect samples from over a million individuals.
Purpose of the Study:
- To evaluate the necessity of preserving viable mononuclear blood cells.
- To assess the feasibility of incorporating viable cell preservation into the biobank's collection plan.
- To support future functional studies and advance precision medicine goals.
Main Methods:
- A workshop was convened in the summer of 2016.
- Discussions focused on the case for preserving viable mononuclear blood cells.
- Feasibility was assessed within the context of the All of Us Research Program's biobank plan.
Main Results:
- Growing interest exists in preserving viable blood cells for advanced analyses.
- Storage of viable cells promises new biological insights and biomarker discovery.
- The workshop aimed to determine the viability of this preservation strategy.
Conclusions:
- Preserving viable mononuclear blood cells is crucial for future single-cell studies.
- This approach holds significant potential for advancing precision medicine.
- Feasibility assessment is key for successful implementation in large-scale biobanks.

